Advertisement
UK markets close in 6 hours 39 minutes
  • FTSE 100

    7,970.99
    +39.01 (+0.49%)
     
  • FTSE 250

    19,820.25
    +9.59 (+0.05%)
     
  • AIM

    741.45
    -0.66 (-0.09%)
     
  • GBP/EUR

    1.1684
    +0.0015 (+0.13%)
     
  • GBP/USD

    1.2593
    -0.0045 (-0.36%)
     
  • Bitcoin GBP

    56,092.73
    +535.56 (+0.96%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CRUDE OIL

    81.76
    +0.41 (+0.50%)
     
  • GOLD FUTURES

    2,216.20
    +3.50 (+0.16%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,500.37
    +23.28 (+0.13%)
     
  • CAC 40

    8,245.30
    +40.49 (+0.49%)
     

BUZZ-AstraZeneca: dives off 1-yr highs after update

** AstraZeneca (NYSE: AZN - news) top of the FTSE 100 fallers' list as some analysts query the sustainability of its EPS beat

** They flag that earnings were enhanced by the partial sell-off of a number of drugs

** Stock called up 1-2 pct by brokers in the pre-market; posts core EPS $1.08 (down 7 pct), above consensus $1.07, but shares dived off 1-yr highs hit recently & drop nearly 3 pct

** Deutsche Bank (Xetra: 514000 - news) reckons further question marks will be raised over the quality of earnings from the base business, though expects consensus EPS forecasts & pipeline-based investment case to be unchanged; repeats "hold" rating (RM (LSE: RM.L - news) : tricia.wright1.thomsonreuters.com@reuters.net)